Who invested in TelomEye Pharmaceuticals?
TelomEye Pharmaceuticals's investors include RePie Asset Management.
Canada · Seed startup
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$1.0Mraised across 1 round since 2022, from 1 source
TelomEye Pharmaceuticals's investors include RePie Asset Management.
TelomEye Pharmaceuticals has raised $1.0M across 1 round since 2022.
TelomEye Pharmaceuticals's most recent round was a Seed of $1.0M in Nov 2022.
Its most recent round, $1.0M in Nov 2022, is also its largest on record.
TelomEye Pharmaceuticals's first round on record, in Nov 2022, was backed by RePie Asset Management.
TelomEye Pharmaceuticals's latest named round is a Seed, in Nov 2022.
TelomEye Pharmaceuticals is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.